Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
  • Sign in
    My account
    Logout
AI 90-DAY FORECAST
BEARISH SIGNAL DETECTED · Alpha
██.█% Sign up free to reveal

Conmed Corp (CNMD) AI Forecast

Our AI ranks Conmed Corp outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

✓ Free account • ✓ 30-day free trial

$CNMD Bearish Signal Full forecast available
Sign Up Free

Conmed Corp (CNMD) Stock Forecast Sept. 21, 2026

Conmed Corp (CNMD) AI Stock Price Forecast & Investment Analysis

Conmed Corp Stock Price Chart and Technical Analysis

Loading chart...

Conmed Corp (CNMD) - Comprehensive Stock Analysis & Investment Research

Deep dive into Conmed Corp's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on September 21, 2026 (UTC)

Conmed Corp Investment Summary

When evaluating whether Conmed Corp (CNMD) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Conmed Corp (CNMD) operates within the Industrial Applications and Services sector, specifically in the Electromedical & Electrotherapeutic Apparatus industry. . With a market capitalization of $1 billion, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Conmed Corp's revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Conmed Corp along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Conmed Corp is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Conmed Corp

Sign Up Free
Corporate Identity

Conmed Corp (Stock Symbol: CNMD) is a prominent company operating within the Industrial Applications and Services sector, with a specific focus on the Electromedical & Electrotherapeutic Apparatus industry. The company's shares are publicly traded on the NYSE exchange.

Leadership & Workforce

Detailed information about Conmed Corp's leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Conmed Corp...

Sector & Industry Analysis

In-depth sector dynamics and industry context for Conmed Corp...

Unlock Full Company Profile

Get complete details about Conmed Corp

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Conmed Corp...

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Conmed Corp...

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Conmed Corp...

Unlock Financial Analysis

Get complete financial metrics for Conmed Corp

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Conmed Corp's AI Price Forecast

Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

4537 Stocks in the out-of-sample test
73.7% Rebalance periods with a positive net return
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Conmed Corp strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Conmed Corp competes within the Industrial Applications and Services sector, navigating the competitive dynamics and market forces specific to this industry. The company's competitive position depends on its ability to differentiate through product quality, cost efficiency, customer relationships, or other strategic advantages relevant to its specific market segment.

Operational Efficiency
Margin & Pricing Power Analysis

The company maintains a 55.1% gross margin indicating healthy pricing power relative to direct production costs. This margin level suggests the company has successfully differentiated its products or services, allowing it to command prices meaningfully above input costs. Maintaining these margins requires ongoing investment in brand, technology, or other differentiating factors.

Operating margin of 8.8% demonstrates how efficiently the company converts revenues into operating profits after accounting for all operating expenses including research and development, sales and marketing, and general administrative costs. Operating margin compression relative to gross margin suggests high operating expenses that may warrant efficiency improvements or reflect necessary growth investments.

Financial Strength & Leverage

Current ratio of 1.48 indicates adequate liquidity to meet short-term obligations with reasonable cushion. This level balances working capital efficiency with financial safety.

Conmed Corp (CNMD) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Conmed Corp stock analysis.

Deep dive into Conmed Corp's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Conmed Corp stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Conmed Corp:

P/B Ratio 1.31x
Market Cap $1.36B
EPS $2.09
Book Value/Share $34.77
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Conmed Corp converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Conmed Corp: An ROE of 6.2% indicates room for improvement in shareholder value creation.

ROE 6.2%
ROA 2.8%
ROIC 6.7%
Gross Margin 55.1%
Operating Margin 8.8%
Net Margin 4.6%
EBT Margin 6.8%
Tax Rate 32.4%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Conmed Corp's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Conmed Corp: A current ratio of 1.48 shows adequate liquidity.

Current Ratio 1.48x
Quick Ratio 0.69x
D/E Ratio 1.21x
Financial Leverage 2.21x
Interest Coverage 4.6x
Working Capital $220M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Conmed Corp's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Conmed Corp:

Operating Cash Flow $180M
OCF Growth YoY 0.2%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Conmed Corp uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Conmed Corp:

Inventory Turnover 1.7x
Days Inventory 210 days
Payables Period 59 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Conmed Corp's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Conmed Corp:

Income Statement
Operating Income $123M
Net Income $64M
R&D Expense $58M
SG&A Expense $589M
Cost of Goods Sold $627M
Balance Sheet Highlights (USD millions)
Total Current Assets $676M (29.4% of assets)
Cash & Short-term Investments $37M (1.6% of assets)
Accounts Receivable $240M (10.4% of assets)
Inventory $360M (15.7% of assets)
Total Liabilities $1.26B (54.7% of assets)
Short-term Debt $354M (15.4% of assets)
Dividend & Shareholder Information
Shares Outstanding 30M

Latest Conmed Corp Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Conmed Corp (CNMD) stock price and investment outlook.

More news available

Sign up free to read all 11 news articles and stay updated on market developments.

Sign Up Free to Read More

Where CNMD sits on the market map

Explore the map →

Conmed Corp Industry Peers - Electromedical & Electrotherapeutic Apparatus

Companies classified under the same SEC industry code as Conmed Corp (Electromedical & Electrotherapeutic Apparatus): 33 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Company Ticker Symbol 90-Day AI Forecast (Alpha) Market Cap (USD M) P/E Ratio P/B Ratio
CNMD ██% $1.36B x 1.3x
MDT ██% $117.85B 22.5x 2.4x
LIVN ██% $4.30B 22.8x 3.2x
ITGR ██% $4.29B x 2.5x
TMDX ██% $3.00B 19.8x 5.8x
ECOR ██% $2.66B x x
AXGN ██% $2.38B x 9.3x
BLFS ██% $1.79B 31.0x 4.3x
CBLL ██% $935M x 7.3x
INMD ██% $909M x 1.3x
CV ██% $335M x 25.5x
ELMD ██% $222M 19.6x 4.1x
FOCL ██% $156M x x
STXS ██% $133M x x
VANI ██% $107M x 5.7x
NRXS ██% $96M x 14.2x
HYPR ██% $83M x 2.3x
STEX ██% $72M x 0.5x
OM ██% $59M x 0.6x
POSC ██% $58M x x
VASO ██% $51M x 1.8x
POCI ██% $49M x 2.4x
QTI ██% $38M x 17.0x
IRIX ██% $12M x 3.2x
ITOC ██% $5M x 0.8x
NXL ██% $4M x 2.4x
ADMT ██% $3M x 5.6x
ESMC ██% $1M x 0.3x
GTHP ██% N/A x x
HCIL ██% N/A x x
NDRA ██% N/A x x
NUWE ██% N/A x x
YBGJ ██% N/A x x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Conmed Corp Stock Forecast

How accurate are Conmed Corp stock predictions?

A per-ticker accuracy statistic for CNMD is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

What factors influence Conmed Corp stock price forecasts?

Our analysis considers Conmed Corp's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Conmed Corp a good investment in 2026?

Based on our AI analysis, Conmed Corp shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Conmed Corp forecasts updated?

Conmed Corp forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on September 21, 2026.

Want a simpler view of Conmed Corp?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...